Skip to Content

Join the 'Pomalyst' group to help and get support from people like you.

Pomalyst Support Group

No questions were found associated with the 'Pomalyst' support group.

Further Information

Related Condition Support Groups

Multiple Myeloma

Pomalyst Patient Information at Drugs.com

Latest News

FDA Approves Empliciti (elotuzumab) Plus Pomalidomide and Dexamethasone, a New Immunotherapy Combination for Certain Patients with Relapsed or Refractory Multiple Myeloma

PRINCETON, N.J.--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE: BMY) today announced that the U.S. Food and Drug Administration (FDA) approved Empliciti (elotuzumab) injection for intravenous ...

Read more news...

Ask a Question